A.R.T. Advisors’s Cascadian Therapeutics, Inc. CASC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
2017
Q3
$44K Sell
2017
Q2
$42K Sell
2017
Q1
$140K Buy
2016
Q3
Sell
2016
Q2
$213K Buy
2016
Q1
$116K Sell
2015
Q4
$864K Buy
2014
Q3
Sell
2014
Q2
$257K Buy
2014
Q1
$148K Sell
2013
Q4
$111K Hold
2013
Q3
$130K Buy
2013
Q2
$23K Buy